EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
State Street Corp Has $6.09 Billion Holdings in Bristol Myers Squibb Company $BMY
State Street Corp Has $6.09 Billion Stock Position in Bristol Myers Squibb Company $BMY - Stock Observer
Trastuzumab plus nivolumab with gemcitabine and cisplatin as first-line therapy for HER2-positive unresectable biliary tract cancer: a phase 1b/2 trial
BMY vs GILD: Which Biotech Stock Looks More Attractive Now?
Pancreatic Endocrine Tumor Market Outlook 2034: Growth Trends, Competitive Landscape, and Future Opportunities - DelveInsight | ABNewswire
Did VOXZOGO's Hypochondroplasia Win and New R&D Hire Just Reframe BioMarin's (BMRN) Investment Narrative?
BMY vs. ARGX: Which Stock Is the Better Value Option?
Pfizer's Dividend Yield Is Enormous. But Is the Payout Still Growing?
Bristol Myers Squibb (BMY) Funds India Lung Cancer Screening Research Beyond Smoking
Bristol-Myers Squibb (BMY), What Is Behind The Fresh Attention?
The exposome and inflammatory bowel disease: a framework for primary and primordial prevention
Bristol Myers Squibb (BMY) Stock Sinks As Market Gains: What You Should Know
Bristol Myers Squibb Presents Sotyktu (deucravacitinib) Data Showing Durable Efficacy, Consistent Safety in Adults with Psoriatic Arthritis Over Two Years | Morningstar
BMY: Late Stage Pipeline Milestones Will Drive Future Re Rating Narrative
Bristol Myers Squibb Company Declares Quarterly Dividend of $0.63 (NYSE:BMY)
Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know
Bristol Myers Squibb Declares Quarterly Dividend As Part Of Ongoing Shareholder Return Strategy
Bristol Myers Squibb identifies new muscarinic receptor agonists | BioWorld
Dr Reddy's forays into Indian biosimilar immuno-oncology market
Dr Reddy's Launches Nivorz: A Game-Changer in India's Cancer Treatment Market, ETPharma
Dr Reddy's launches Opdivo biosimilar Nivorz in India, enters immuno-oncology segment
Zacks Research Has Positive Outlook for BMY Q3 Earnings - Zolmax
The Bull Case For Bristol Myers Squibb (BMY) Could Change Following Arlo-cel's Positive Phase 2 Myeloma Data
Lockheed's Pension Risk Transfer Appeal Tests Retiree Rights
Zacks Research Issues Positive Estimate for BMY Earnings - Daily Political
RBC Capital Sticks to Their Buy Rating for AstraZeneca (AZN)
RBC Capital Sticks to Their Buy Rating for Roche Holding AG (RHHVF)
RBC Capital Sticks to Their Buy Rating for AbbVie (ABBV)
GlaxoSmithKline (GSK) Gets a Hold from RBC Capital
RBC Capital Sticks to Their Hold Rating for Merck & Company (MRK)
RBC Capital Sticks to Their Hold Rating for Bristol-Myers Squibb (BMY)
RBC Capital Keeps Their Hold Rating on Novartis AG (NOVN)
RBC Capital Sticks to Their Buy Rating for Eli Lilly & Co (LLY)
Should You Buy Bristol Myers Squibb Stock Right Now for the Yield Alone?
Clinical usability of an explainable AI decision support tool and evaluation of multimodal models in NSCLC
How Much Do You Really Need Invested in Bristol Myers Squibb to Collect $10,000 a Year?
Bristol Myers Squibb Company $BMY Shares Bought by The Manufacturers Life Insurance Company
New FDA Drug Approvals - August 2026
Bristol Myers' Cancer Therapy Win Strengthens its Oncology Pipeline
RBC Capital Sticks to Its Buy Rating for Johnson & Johnson (JNJ)
RBC Capital Reaffirms Their Hold Rating on Bristol-Myers Squibb (BMY)
Bristol Myers Squibb (BMY) Declines More Than Market: Some Information for Investors
Investors Purchase Large Volume of Put Options on Bristol Myers Squibb (NYSE:BMY) - Zolmax
BMY Gains 19.4% Year to Date: Should You Buy, Sell or Hold the Stock?
Investors Purchase Large Volume of Put Options on Bristol Myers Squibb (NYSE:BMY) - Daily Political
Cloud vs On-Prem AI in 2026: Is Renting GPUs Cheaper Than Buying AI Servers?
Graft Versus Host Disease Market to Reach Significant Growth by 2036, Driven by Rising Transplant Procedures, Targeted Therapies, and Emerging Cell-based Treatment Approaches | DelveInsight | ABNewswire
Eosinophilic Esophagitis Market: Rapid Increment Driven by Innovation by 2036 - DelveInsight | Regeneron, Sanofi, Bristol-Myers Squibb, Ellodi Pharma, AstraZeneca, Allakos, EsoCap AG, Pfizer, Ception | ABNewswire
A bispecific CD3×CD19 antibody for systemic lupus erythematosus: a phase 1 trial
Glioblastoma Clinical Trial Pipeline Appears Robust With 200+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight | ABNewswire
Multiple Myeloma Market Poised for Sustained Growth Amid Advancements in Treatment and Clinical Innovation by 2036 - DelveInsight | Regeneron, Sanofi, Arcellx, Gilead, AbbVie, Bristol-Myers Squibb | ABNewswire
Interstitial Lung Disease Market Size is Projected to Grow from USD 6 Billion at a CAGR of 8.7% By 2036| DelveInsight | ABNewswire
Interstitial Lung Disease Clinical Trial Drug Development Pipeline Expands with Contributions from 120+ Key Companies | DelveInsight | ABNewswire
REBLOZYL Sales Forecast and Market Size Analysis 2020-2034 | New Indications Broaden REBLOZYL Market Potential | Valuespectrum.com
Could Bristol-Myers Squibb (BMY) Outperform Novartis (NVS) as CAR-T Safety Concerns Shake the Sector?
Will The Recent Pipeline Progress Boost BMY's Portfolio Expansion?
BMS reports positive data from Phase II QUINTESSENTIAL study for r/r MM
Bristol Myers Squibb Reports Positive Phase 2 Results For Arlo-cel In Multiple Myeloma
Bristol Myers' Breakthrough Cell Therapy for Blood Cancer Shows Promising Results in Mid-Stage Trial, ETPharma
Bristol Myers Squibb Company $BMY Shares Purchased by Waverly Advisors LLC - Daily Political
RBC Capital downgrades Novartis AG (NOVN) to a Hold
RBC Capital downgrades GlaxoSmithKline (GSK) to a Hold
RBC Capital Reaffirms Their Buy Rating on AstraZeneca (AZN)
Carmignac Gestion Buys New Shares in Bristol Myers Squibb Company $BMY - Zolmax
RBC Capital Initiates a Hold Rating on Sanofi (SNYNF)
Bristol-Myers Squibb Co (BMY) Shares Fall 3.2% -- What GF Score
Social Security's 2027 COLA Raise Is the Biggest in 3 Years - But These 5 Dividend Stocks Pay You More
Bristol Myers' blood cancer cell therapy meets main goal in mid-stage trial
Bristol Myers Squibb Announces Positive Topline Results from Registrational Phase 2 QUINTESSENTIAL Trial of the Potential First-in-Class GPRC5D-Directed CAR T Cell Therapy, Arlocabtagene Autoleucel ... | Morningstar
Bristol Myers Squibb Company $BMY Shares Acquired by Amundi
Bristol Myers Squibb Company $BMY Shares Sold by HighTower Advisors LLC - Daily Political
Chronic Myeloid Leukemia Clinical Trial Pipeline Appears Robust With 25+ Key Pharma Companies Actively Working in the Domain | DelveInsight | Valuespectrum.com
Forget the Dividend. This Could Be the Real Reason to Buy Pfizer Stock Now
Bristol Myers Squibb Company (NYSE:BMY) Receives Average Recommendation of "Moderate Buy" from Analysts - Markets Daily
VIRGINIA RETIREMENT SYSTEMS ET Al Buys Shares of 1,722,230 Bristol Myers Squibb Company $BMY - Stock Observer
Paralel Advisors LLC Buys New Position in Bristol Myers Squibb Company $BMY - Daily Political
Genome-wide association analyses highlight the neuronal contribution to multiple sclerosis susceptibility
Wall Street Money Is Leaving Just As Atrium's (RNA) Pipeline Turns Real
Bristol Myers Squibb Company $BMY Shares Sold by Mid American Wealth Advisory Group Inc.
Bristol Myers Squibb Company $BMY Shares Purchased by NEOS Investment Management LLC
Bristol Myers Squibb Company $BMY Position Boosted by Concurrent Investment Advisors LLC
Bristol Myers Squibb Company $BMY Shares Acquired by Three Seasons Wealth LLC - Stock Observer
7,970 Shares in Bristol Myers Squibb Company $BMY Purchased by OceanIQ Capital LLC - Stock Observer
Why Bristol Myers Squibb (BMY) Dipped More Than Broader Market Today
Alexandria Real Estate Equities, Inc. Highlights Its Role in Advancing Blood Cancer Innovation by Enabling Life-Changing Tenant R&D, Mission-Critical Philanthropic Initiatives and Strategic Investments
Market Chatter: Bristol Myers Squibb Paused Zola-Cel Trials Over Safety Concerns
Bristol Myers Squibb Company $BMY Shares Bought by Burford Brothers Inc.
PD-L1 expression and survival in unresectable/recurrent gastric cancer treated by 1st-line treatment without immune checkpoint inhibitors: JCOG1013A1
Why Is Gilead (GILD) Up 13.6% Since Last Earnings Report?
Eikon Therapeutics Appoints Ching-Pin Chang As Executive VP & Chief Scientific Officer
What Does Bristol Myers Squibb (BMY) Trial Pause Mean For Its Pipeline?
BristolMyers News
Dollar to Mexican Peso Forecast 2026–2030: Can USD/MXN Break Above 17.50 as the Rate Gap Narrows?
Avalanche Price Prediction 2026–2030: Can Institutional Tokenization Push AVAX Back Above $10?
Advanced CFD Trading Tools Review: Which Tools Can Improve Your Trading Decisions?
Latest news
Show more
Intel Stock Surges 12% as AI Chip Rally and SK Hynix Ohio Talks Lift Sentiment
Gold Price Today Rises Above $4,350 as Lower Oil Prices Ease Rate Concerns
Bitcoin Price Today Hits Eight-Month High Above $86,000 as ETF Inflows and Short Squeeze Fuel Rally
AMD Stock Soars 10% and Joins the $1 Trillion Club as AI Chip Rally Returns
Costco Earnings Preview: Can Membership Growth Push COST Stock Higher?
ASML Stock Rises 3% as AI Chip Rally and Samsung High-NA EUV Plans Lift Sentiment
